1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STARS-Pilot (05/55 Graham), NCT00126360
|
|
2.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 70 Sponsor: NIGMS Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
|
|
3.
|
Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: LITE Randomized Pilot Study, NCT00531973
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: YUNZHI-BC, NCT00647075
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 50 and over Sponsor: Other Protocol IDs: S07-002, 1098558, NCT00882596
|
|
6.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09 SEIN 09, NCT01127295
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 45 and over Sponsor: Other Protocol IDs: Mammosite ML, NCT01448447
|
|
8.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Approved-not yet active Age: 20 to 70 Sponsor: Other, Pharmaceutical / Industry Protocol IDs: 2011-91, NCT01571518
|
|
9.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 65 and over Sponsor: Other Protocol IDs: GBG 52, 2008-003995-23, NCT01204437
|
|
10.
|
Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ART-THERAPIE, NCT01331629
|
|
11.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 30 to 70 Sponsor: Other Protocol IDs: MVH-03, 2010-022460-12, 2007-58-0015/HEH.750.89-12, H-4-2011-007, NCT01355523
|
|
12.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: PUMCH- Breast-AH, NCT01413828
|
|
13.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: PUMCH-Breast- AX, NCT01415336
|
|
14.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: jzhang2, NCT01654367
|
|
15.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: Not Specified Sponsor: Other Protocol IDs: xeloda, NCT01662128
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000068827, IBCSG-22-00, EU-20119, EUDRACT-2005-005666-36, NCT00022516
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 96/84 Graham, NCT00138814
|
|
19.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 122 of 2003, NCT00193726
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GBG-GEPARQUATTRO, GBG-40, EU-205101, AVENTIS-GBG-GEPARQUATTRO, ROCHE-AVENTIS-GBG-GEPARQUATTRO, EUDRACT-2005-001546-17, NCT00288002
|
|
21.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment Status: Active Age: 18 to 75 Sponsor: NCI Protocol IDs: ECOG-PACCT-1, PACCT-1, NCT00310180
|
|
22.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CRUK-OPTION, EUDRACT-2004-000133-11, CRUK-BR0402, ISRCTN84856516, EU-20680, NCT00427245
|
|
23.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000526522, EORTC-10041, EUDRACT-2005-002625-31, BIG-3-04, EU-20676, NOVARTIS-EORTC-10041, ROCHE-EORTC-10041, SANOFI-AVENTIS-EORTC-10041, NCT00433589
|
|
24.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: UKM-CCH-ACTION, ICR-CTSU/2006/10004-ACTION, EU-20751, EUDRACT-2005-005721, ISRCTN41708421, BIG-205, BIG 2-05, NCT00516425
|
|
25.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: GIM-3-FATA, GIM3-FATA, EUDRACT-2006-004018-42, EU-20764, NCT00541086
|